Novartis India announced that the Board of Directors of the Company at its meeting held on 9 May 2025, inter alia, have recommended the final dividend of Rs 25 per equity Share (i.e. 500%) , subject to the approval of the shareholders.
Novartis India standalone net profit rises 99.59% in the March 2025 quarter
10 - May - 2025 12:00 | 40 days ago
Net profit of Novartis India rose 99.59% to Rs 29.30 crore in the quarter ended March 2025 as against Rs 14.68 crore during the previous quarter ended March 2024. Sales rose 3.34% to Rs 83.88 crore in the quarter ended March 2025 as against Rs 81.17 crore during the previous quarter ended March 2024.
For the full year,net profit rose 18.44% to Rs 100.90 crore in the year ended March 2025 as against Rs 85.19 crore during the previous year ended March 2024. Sales rose 6.33% to Rs 356.27 crore in the year ended March 2025 as against Rs 335.07 crore during the previous year ended March 2024.
Novartis India standalone net profit rises 99.59% in the March 2025 quarter
10 - May - 2025 12:00 | 40 days ago
Net profit of Novartis India rose 99.59% to Rs 29.30 crore in the quarter ended March 2025 as against Rs 14.68 crore during the previous quarter ended March 2024. Sales rose 3.34% to Rs 83.88 crore in the quarter ended March 2025 as against Rs 81.17 crore during the previous quarter ended March 2024.
For the full year,net profit rose 18.44% to Rs 100.90 crore in the year ended March 2025 as against Rs 85.19 crore during the previous year ended March 2024. Sales rose 6.33% to Rs 356.27 crore in the year ended March 2025 as against Rs 335.07 crore during the previous year ended March 2024.
Novartis India announced that the Board of Directors of the Company at its meeting held on 9 May 2025, inter alia, have recommended the final dividend of Rs 25 per equity Share (i.e. 500%) , subject to the approval of the shareholders.
Novartis India standalone net profit rises 99.59% in the March 2025 quarter
10 - May - 2025 12:00 | 40 days ago
Net profit of Novartis India rose 99.59% to Rs 29.30 crore in the quarter ended March 2025 as against Rs 14.68 crore during the previous quarter ended March 2024. Sales rose 3.34% to Rs 83.88 crore in the quarter ended March 2025 as against Rs 81.17 crore during the previous quarter ended March 2024.
For the full year,net profit rose 18.44% to Rs 100.90 crore in the year ended March 2025 as against Rs 85.19 crore during the previous year ended March 2024. Sales rose 6.33% to Rs 356.27 crore in the year ended March 2025 as against Rs 335.07 crore during the previous year ended March 2024.
Novartis India announced that the Board of Directors of the Company at its meeting held on 9 May 2025, inter alia, have recommended the final dividend of Rs 25 per equity Share (i.e. 500%) , subject to the approval of the shareholders.
Novartis India standalone net profit rises 99.59% in the March 2025 quarter
10 - May - 2025 12:00 | 40 days ago
Net profit of Novartis India rose 99.59% to Rs 29.30 crore in the quarter ended March 2025 as against Rs 14.68 crore during the previous quarter ended March 2024. Sales rose 3.34% to Rs 83.88 crore in the quarter ended March 2025 as against Rs 81.17 crore during the previous quarter ended March 2024.
For the full year,net profit rose 18.44% to Rs 100.90 crore in the year ended March 2025 as against Rs 85.19 crore during the previous year ended March 2024. Sales rose 6.33% to Rs 356.27 crore in the year ended March 2025 as against Rs 335.07 crore during the previous year ended March 2024.
Novartis India standalone net profit rises 99.59% in the March 2025 quarter
10 - May - 2025 12:00 | 40 days ago
Net profit of Novartis India rose 99.59% to Rs 29.30 crore in the quarter ended March 2025 as against Rs 14.68 crore during the previous quarter ended March 2024. Sales rose 3.34% to Rs 83.88 crore in the quarter ended March 2025 as against Rs 81.17 crore during the previous quarter ended March 2024.
For the full year,net profit rose 18.44% to Rs 100.90 crore in the year ended March 2025 as against Rs 85.19 crore during the previous year ended March 2024. Sales rose 6.33% to Rs 356.27 crore in the year ended March 2025 as against Rs 335.07 crore during the previous year ended March 2024.
